CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 191 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $1,312,000 | -4.0% | 67,993 | -41.3% | 0.19% | +18.5% |
Q2 2017 | $1,367,000 | -53.7% | 115,811 | -57.0% | 0.16% | -43.9% |
Q1 2017 | $2,951,000 | -10.9% | 269,227 | -41.0% | 0.29% | +4.3% |
Q4 2016 | $3,313,000 | +31.2% | 456,389 | +17.4% | 0.28% | +14.9% |
Q3 2016 | $2,526,000 | +49.2% | 388,582 | +25.3% | 0.24% | +3.4% |
Q2 2016 | $1,693,000 | +28.3% | 310,029 | +9.9% | 0.23% | +28.7% |
Q1 2016 | $1,320,000 | -15.0% | 282,030 | -9.5% | 0.18% | -8.1% |
Q4 2015 | $1,553,000 | +50.5% | 311,759 | +13.6% | 0.20% | +20.9% |
Q3 2015 | $1,032,000 | +3.3% | 274,419 | +65.2% | 0.16% | 0.0% |
Q2 2015 | $999,000 | +23.0% | 166,150 | +14.6% | 0.16% | +55.2% |
Q1 2015 | $812,000 | +108.7% | 144,950 | +11.8% | 0.10% | +90.9% |
Q4 2014 | $389,000 | +213.7% | 129,692 | +180.1% | 0.06% | +175.0% |
Q3 2014 | $124,000 | -42.1% | 46,300 | -39.4% | 0.02% | -50.0% |
Q2 2014 | $214,000 | +103.8% | 76,400 | +217.0% | 0.04% | +29.0% |
Q1 2014 | $105,000 | +78.0% | 24,100 | +31.0% | 0.03% | +29.2% |
Q4 2013 | $59,000 | – | 18,400 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INGALLS & SNYDER LLC | 8,712,176 | $123,147,000 | 6.01% |
TANAKA CAPITAL MANAGEMENT INC | 74,139 | $1,048,000 | 3.38% |
S&T BANK/PA | 625,078 | $8,859,000 | 1.92% |
Parallel Advisors, LLC | 1,277,851 | $18,062,000 | 1.55% |
AJ WEALTH STRATEGIES, LLC | 595,828 | $8,422,000 | 1.11% |
Matarin Capital Management, LLC | 891,636 | $12,603,000 | 0.95% |
Capital Impact Advisors, LLC | 162,544 | $2,370,000 | 0.90% |
AMI ASSET MANAGEMENT CORP | 775,685 | $10,964,000 | 0.57% |
Birchview Capital, LP | 50,000 | $707,000 | 0.47% |
Zebra Capital Management LLC | 25,409 | $359,000 | 0.39% |